コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 esicular body protein 2B (CHMP2B) gene cause frontotemporal lobar degeneration.
2 these disorders and other clinical forms of frontotemporal lobar degeneration.
3 hic lateral sclerosis and ubiquitin-positive frontotemporal lobar degeneration.
4 1S human tau mutation, which causes familial frontotemporal lobar degeneration.
5 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
6 es such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
7 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
8 s prediction of histopathological subtype of frontotemporal lobar degeneration.
9 ple of patients with pathologically verified frontotemporal lobar degeneration.
10 Alzheimer's disease, Lewy body disease, and frontotemporal lobar degeneration.
11 established criteria in a sample with known frontotemporal lobar degeneration.
12 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
13 ogranulin gene are a major cause of familial frontotemporal lobar degeneration.
14 cellular apoptosis susceptibility protein in frontotemporal lobar degeneration.
15 e in the pathogenesis of the TDP-43 positive frontotemporal lobar degeneration.
16 o differentiate and track different types of frontotemporal lobar degeneration.
17 e considered a separate syndromic variant of frontotemporal lobar degeneration.
18 s now considered one of the main variants of frontotemporal lobar degeneration.
19 ity are common and disabling consequences of frontotemporal lobar degeneration.
20 n patients suffering from AD from those with frontotemporal lobar degeneration.
21 s the latest developments in the genetics of frontotemporal lobar degeneration.
22 ne were identified in patients with familial Frontotemporal Lobar Degeneration.
23 D), progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration.
24 thogenesis amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
25 tive disorders in addition to ALS, including frontotemporal lobar degeneration.
26 l forms of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
27 ures through which TMEM106B confers risk for frontotemporal lobar degeneration.
28 e diseases amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
29 otrophic lateral sclerosis and some types of frontotemporal lobar degeneration.
30 us and risk of the neurodegenerative disease frontotemporal lobar degeneration.
31 iverse clinical syndromes, all attributed to frontotemporal lobar degeneration.
32 e disorders, including Parkinson disease and frontotemporal lobar degeneration.
33 lusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
35 f-function mutations in the PGRN gene causes frontotemporal lobar degeneration accompanied by TDP-43
36 nded repeat carriers were also identified in frontotemporal lobar degeneration, Alzheimer's and Parki
37 veral neurodegenerative disorders, including frontotemporal lobar degeneration, amyotrophic lateral s
38 cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnos
39 form the diagnostic signature inclusions of frontotemporal lobar degeneration and amyotrophic latera
40 d array of TDP-43 proteinopathies, including frontotemporal lobar degeneration and amyotrophic latera
41 with neurodegenerative diseases, especially frontotemporal lobar degeneration and amyotrophic latera
42 e protein aggregates in distinct subtypes of frontotemporal lobar degeneration and amyotrophic latera
43 to the differentiation between syndromes of frontotemporal lobar degeneration and focal forms of Alz
44 co-registered magnetic resonance imaging in frontotemporal lobar degeneration and imaging of nigrost
45 siology of amyotrophic lateral sclerosis and frontotemporal lobar degeneration and is essential for e
46 been identified as a major cause of familial frontotemporal lobar degeneration and motor neuron disea
48 dementia with Lewy bodies, 55 patients with frontotemporal lobar degeneration), and scans from 73 he
49 ive diseases, including Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disea
50 n samples from patients with TDP-43 positive frontotemporal lobar degeneration, and spinal cord sampl
51 ies including amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and sporadic inclusio
52 th risk of neurodegenerative diseases beyond frontotemporal lobar degeneration are enriched in CTCF-b
54 iate filament inclusion disease and atypical frontotemporal lobar degeneration are rare diseases char
55 ion to other forms of genetically determined frontotemporal lobar degeneration ascertained at a speci
56 lin (GRN) is a major genetic risk factor for frontotemporal lobar degeneration associated with TDP-43
57 ons in two TDP-43 proteinopathies, including frontotemporal lobar degeneration associated with TDP-43
59 6B rs1990622 polymorphism is associated with frontotemporal lobar degeneration, but little is known a
60 erative disorders, including the majority of frontotemporal lobar degeneration cases (FTLD-TDP), moto
61 total) were identified, representing 35% of frontotemporal lobar degeneration cases with identified
63 ologically ascertained cohort of 95 cases of frontotemporal lobar degeneration classified according t
64 the voxel-based morphometry analysis of the frontotemporal lobar degeneration cohort, pain and tempe
66 inical importance of the C9ORF72 mutation in frontotemporal lobar degeneration, delineate phenotypic
68 t, we observed that alpha-synucleinopathies, frontotemporal lobar degeneration due to tau and TAR DNA
69 tive disease diagnosis (Alzheimer's disease, frontotemporal lobar degeneration due to tau, and TAR DN
71 s in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, followed by the disco
73 nation [MMSE] score +/- SD, 22.2 +/- 6.0) or frontotemporal lobar degeneration (FTLD) (n = 31; age +/
75 s correlate with postmortem tau pathology in frontotemporal lobar degeneration (FTLD) and (2) tauopat
76 nding protein that forms inclusion bodies in frontotemporal lobar degeneration (FTLD) and amyotrophic
78 at expansion in C9orf72 is a common cause of frontotemporal lobar degeneration (FTLD) and amyotrophic
79 ficant heterogeneity in clinical features of frontotemporal lobar degeneration (FTLD) and amyotrophic
80 t expansions in C9orf72 are a major cause of frontotemporal lobar degeneration (FTLD) and amyotrophic
81 e (GRN) is mutated in 5-10% of patients with frontotemporal lobar degeneration (FTLD) and in about 20
82 rogranulin (PGRN) gene (GRN) causes familial frontotemporal lobar degeneration (FTLD) and modulates a
86 lusions of amyotrophic lateral sclerosis and frontotemporal lobar degeneration (FTLD) characterized b
88 oses included Alzheimer's disease in 45% and frontotemporal lobar degeneration (FTLD) in the others,
96 neuropathologic entities, including forms of frontotemporal lobar degeneration (FTLD) or Alzheimer di
98 re reviewed that help identify patients with frontotemporal lobar degeneration (FTLD) spectrum abnorm
99 h elderly control subjects and patients with frontotemporal lobar degeneration (FTLD) to determine wh
101 aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DN
102 actor in a genome-wide association study for frontotemporal lobar degeneration (FTLD) with TAR DNA-bi
103 l FTD cases are classified pathologically as frontotemporal lobar degeneration (FTLD) with TAR DNA-bi
104 uopathies, include Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD) with tau pathol
105 ), progressive supranuclear palsy (13%), and frontotemporal lobar degeneration (FTLD) with TDP inclus
106 linical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactiv
107 ranulin gene (GRN) are an important cause of frontotemporal lobar degeneration (FTLD) with ubiquitin
108 rise amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitin
109 c of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitin-
110 age 63, neuropathologic examination revealed frontotemporal lobar degeneration (FTLD) with ubiquitin-
111 d in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitina
112 98 with a primary pathological diagnosis of frontotemporal lobar degeneration (FTLD), 15 with Alzhei
114 utations in the progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD), a progressive
115 fulfilling clinical diagnostic criteria for frontotemporal lobar degeneration (FTLD), and 259 patien
116 mutations in the granulin (GRN) gene causes frontotemporal lobar degeneration (FTLD), and complete l
117 Severe empathy loss is a common feature of frontotemporal lobar degeneration (FTLD), and is also se
118 d to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), but it is not
119 ic ALS, ALS mimics (disease controls (DCo)), frontotemporal lobar degeneration (FTLD), Creutzfeldt-Ja
120 ral sclerosis (ALS) and approximately 50% of frontotemporal lobar degeneration (FTLD), designated as
121 tive dementias, Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD), has greatly ad
122 ost common clinical syndrome associated with frontotemporal lobar degeneration (FTLD)--and several pr
123 inclusions in TDP-43 proteinopathies such as frontotemporal lobar degeneration (FTLD)-TDP are made of
142 veral neurodegenerative disorders, including frontotemporal lobar degeneration (FTLD-TDP) and amyotro
143 Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP) are two neu
150 ment was more severe in the temporal variant frontotemporal lobar degeneration group than the Alzheim
152 atients with semantic dementia, a variant of frontotemporal lobar degeneration, has emerged over the
155 y cause disease in patients with a subset of frontotemporal lobar degeneration; however, the biologic
156 made in our understanding of the genetics of frontotemporal lobar degeneration in recent years, the m
157 racteristic of human Alzheimer's disease and frontotemporal lobar degeneration, including beta-amyloi
158 ose humans to amyotrophic lateral sclerosis, frontotemporal lobar degeneration, inclusion body myopat
159 he spectrum of pathological changes found in frontotemporal lobar degeneration involving the microtub
166 ders, including Alzheimer's disease (AD) and frontotemporal lobar degeneration, is associated with di
167 d to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, is important for the
169 ase at the mild stage (N = 16 patients) from frontotemporal lobar degeneration (N = 11 patients) and
170 nonical dementia syndromes: temporal variant frontotemporal lobar degeneration (n = 14) and Alzheimer
171 or temperature for a cohort of patients with frontotemporal lobar degeneration (n = 58, 25 female, ag
172 nalysis of the 7p21 locus linked by GWASs to frontotemporal lobar degeneration, nominating a causal v
173 s of frontal lobe dysfunction resulting from frontotemporal lobar degeneration or Alzheimer's disease
175 he neuroanatomical specificity of particular frontotemporal lobar degeneration pathologies may depend
176 Subtyping PPA helps to predict AD versus frontotemporal lobar degeneration pathology at the group
177 opathies, which include Alzheimer's disease, frontotemporal lobar degeneration, Pick's disease, progr
178 relative paucity of information relating to frontotemporal lobar degeneration primarily affecting th
179 to complex behavioural changes arising from frontotemporal lobar degeneration provides new insights
180 riant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopatholo
181 Here we report that the recently identified frontotemporal lobar degeneration risk factor TMEM106B u
182 and may shed light on the regulation of the frontotemporal lobar degeneration risk factor TMEM106B.
183 in six cases with C9ORF72 mutation from the frontotemporal lobar degeneration series identified hist
185 to clinical phenotypes, particularly in the frontotemporal lobar degeneration spectrum, but the basi
187 c forms of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, suggesting that eithe
189 distinct from previously published cases of frontotemporal lobar degeneration TAR DNA protein 43.
190 otein-43 deposition in 53 control cases with frontotemporal lobar degeneration-TAR DNA-binding protei
191 pathological diagnosis of Alzheimer disease, frontotemporal lobar degeneration-tau, frontotemporal lo
193 amilial neurodegenerative disorder, known as frontotemporal lobar degeneration tauopathy (FTLD-Tau),
194 linical diagnoses of one of the syndromes of frontotemporal lobar degeneration, the high proportion r
195 h groups of pathologies from the spectrum of frontotemporal lobar degeneration: the most frequent wer
196 t-mortem confirmed diagnosis of either AD or frontotemporal lobar degeneration to their respective gr
197 ease, frontotemporal lobar degeneration-tau, frontotemporal lobar degeneration-transactive response D
199 r spinal cords from 22 cases with or without frontotemporal lobar degeneration were also studied.
200 but particularly severe in temporal variant frontotemporal lobar degeneration, whereas impairments o
201 included in investigations of patients with frontotemporal lobar degenerations who show unusual whit
202 cases and two cases of ALS plus concomitant frontotemporal lobar degeneration with a remarkable conc
203 ation mechanisms might instead be related to frontotemporal lobar degeneration with abnormal TARDBP.
204 ntic scores across a set of 21 patients with frontotemporal lobar degeneration with semantic impairme
205 that, when deficient, is linked to cases of frontotemporal lobar degeneration with TAR DNA-binding p
206 hies, including Alzheimer's disease (AD) and frontotemporal lobar degeneration with tau pathologies,
210 esulting in protein haploinsufficiency cause frontotemporal lobar degeneration with TDP-43 inclusions
211 aracterize amyotrophic lateral sclerosis and frontotemporal lobar degeneration with TDP-43 inclusions
212 ressive aphasia and, at autopsy, showed both frontotemporal lobar degeneration with TDP-43 inclusions
213 06B variants are genetically associated with frontotemporal lobar degeneration with TDP-43 pathology
214 ents with amyotrophic lateral sclerosis, and frontotemporal lobar degeneration with TDP-43 positive u
215 with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43(+) inclusi
217 sclerosis (ALS) and frontotemporal dementia-frontotemporal lobar degeneration with TDP-43-positive i
218 hological subtype of frontotemporal dementia-frontotemporal lobar degeneration with TDP-43-positive i
219 at there exists a unique association between frontotemporal lobar degeneration with type C pathology
220 a secreted glycoprotein, is a major cause of frontotemporal lobar degeneration with ubiquitin (FTLD-U
221 rtial loss of the encoded PGRN protein cause frontotemporal lobar degeneration with ubiquitin immunor
223 n (PGRN) cause the neurodegenerative disease frontotemporal lobar degeneration with ubiquitin inclusi
224 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin positiv
225 Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin positiv
226 bodies (DLB), mixed Alzheimer's disease/DLB, frontotemporal lobar degeneration with ubiquitin-only-im
227 luding: amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration with ubiquitin-positiv
228 s of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positiv
229 pal component of ubiquitinated inclusions in frontotemporal lobar degeneration with ubiquitin-positiv
230 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positiv
232 ied as the pathological signature protein in frontotemporal lobar degeneration with ubiquitin-positiv
233 is (ALS), a fatal motor neuron disorder, and frontotemporal lobar degeneration with ubiquitin-positiv
234 re the defining histopathological feature of frontotemporal lobar degeneration with ubiquitin-positiv
235 rotein 43 (TDP-43) is the disease protein in frontotemporal lobar degeneration with ubiquitin-positiv
236 progranulin gene (GRN) are a major cause of frontotemporal lobar degeneration with ubiquitin-positiv
237 ubstrate of neuronal and glial inclusions in frontotemporal lobar degeneration with ubiquitin-positiv
238 athological protein of sporadic and familial frontotemporal lobar degeneration with ubiquitin-positiv
239 nuclein-negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positiv
240 opathologically, HDDD2 represents a familial frontotemporal lobar degeneration with ubiquitin-positiv
242 opathy in the nonfluent cases (10 of 23) and frontotemporal lobar degeneration with ubiquitin-positiv
243 d shown to be more insoluble in the atypical frontotemporal lobar degeneration with ubiquitinated inc
244 iate filament inclusion disease and atypical frontotemporal lobar degeneration with ubiquitinated inc
246 ll as the caudate in the cases with atypical frontotemporal lobar degeneration with ubiquitinated inc
247 k of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitinated inc
248 present in the hallmark inclusion bodies of frontotemporal lobar degeneration with ubiquitinated inc
249 is study aimed to determine the frequency of frontotemporal lobar degeneration with ubiquitinated inc
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。